Sonnet Biotherapeutics Holdings Inc (SONN) — Cash Flow Reinvestment Rate
Latest as of March 2024:
0.00x
Sonnet Biotherapeutics Holdings Inc (SONN) has a Cash Flow Reinvestment Rate of 0.00x as of March 2024, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $723.79K. Check cash flow quality index of Sonnet Biotherapeutics Holdings Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$723.79K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Sonnet Biotherapeutics Holdings Inc (None–None)
Year-by-year capital reinvestment analysis for Sonnet Biotherapeutics Holdings Inc. For live market cap and broader valuation context, see Sonnet Biotherapeutics Holdings Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow